Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

New Market Opportunities May Open up for Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) as a Cookie-less Future Fast Approaches

The online advertising ecosystem is transforming as governments worldwide ramp up regulations to rein in collection of consumers’ personal data Google’s Privacy Sandbox works toward the end of third-party cookies in Chrome, giving rise to a whole new privacy-compliant identity ecosystem As a company driven by the evolution of data privacy and its impact on […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Approved to Proceed with Human Study Evaluating Effectiveness of Patented DehydraTECH(TM) Technology in Boosting Oral-Tissue Absorption of Nicotine

Lexaria Bioscience recently received Independent Review Board approval for its upcoming human clinical nicotine study, NIC-H22-1, and expects to begin dosing soon The company hopes to evidence that processing purified nicotine with its patented DehydraTECH(TM) drug delivery technology leads to better oral-tissue absorption and reduced negative experiences compared to leading brands currently available on the […]

EverGen Infrastructure Corp.’s (TSX.V: EVGN) (OTCQX: EVGIF) FVB Expansion Project Breaks Ground to Provide Lift to Company’s Revenues and EBITDA Amid a Stronger Renewable Natural Gas Market

EverGen commenced construction at its Core RNG Expansion Project at Fraser Valley Biogas; project is advancing on schedule and on budget with expected completion in Q1 2023 Expansion is estimated to double FVB’s capacity to ~160,000 GJ of RNG per year; coupled with new long-term offtake agreement executed in current robust RNG market, it is […]

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) CEO Participated in The American Brain Tumor Association’s Breakthrough for Brain Tumors(R) 5K Run Following European Clinical Trial Site Activations

CNS Pharmaceuticals CEO John Climaco participated in 5K run on November 5, to show support for brain tumor patients worldwide and help raise funds for research The company recently announced European clinical trial site activations for its potentially pivotal global trial evaluating Berubicin for the treatment of recurring glioblastoma multiforme The pivotal trial will study […]

Correlate Infrastructure Partners Inc. (CIPI) Offering Affordable and Profitable ESG-Related Energy Solutions Amid Spike in ESG-Focused Investment

In 2021, a third of the world’s assets under management, including the money of growing numbers of huge public pension funds, were invested according to ESG principles, with the year posting the highest expenditure on ESG initiatives globally Correlate recognizes the growing need for businesses to achieve ESG goals and is looking to meet this […]

Coyuchi Inc. Targets Conscious Consumers with Superior Sustainable Products; Company Reviewed by Investor Analyst News Publication KingsCrowd

Coyuchi is currently accepting investments under its Regulation A+ offering and is approaching the $1 million milestone KingsCrowd has published a review on Coyuchi, highlighting the company’s strengths and future industry challenges to be met The report discusses how few individuals are better suited to run a sustainable company than CEO Eileen Mockus, given her […]

Vision Energy Corp. (VIHDD) Is ‘One to Watch’

Vision Energy in October 2022 announced it had completed conceptual layouts for its Green Energy Hub project in Vlissingen, the Netherlands The company in September 2022 announced its commitment to an additional 5.19 acres, expanding its Green Energy Hub project footprint to a total of 40.53 acres Vision Energy is on schedule to file for […]

Odyssey Health, Inc. (ODYY) Focuses on Medical Devices Market with US Patent Application on Breath-Propelled Intranasal Delivery Device

Odyssey filed for US and global patent protection on its novel breath-propelled, intranasal brain-drug delivery device that effectively deposits concentrated drug deep into the nasal cavity for the treatment of CNS injury disease or disorder The application follows the successful completion of the second Cohort of Odyssey’s Phase I MAD clinical trial, which saw the […]

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Maintains Focus on Advancing Clinical Development Program for Lead Drug Candidate, Berubicin

In June 2020, CNS’ lead drug candidate, Berubicin, received Orphan Drug designation from the FDA. In June 2021, it received Fast Track designation following positive results from an extensive clinical study that saw 44% of the patients post a clinical response, with one Durable Complete Response With GBM having a survival rate of only 6.8% […]

 

From Our Blog

Leading Solana Treasury Company Forward Industries Inc. (NASDAQ: FWDI) Authorizes $1 Billion Share Repurchase Program and Files a Resale Prospectus Supplement

November 20, 2025

Forward Industries (NASDAQ: FWDI), a company building and managing a large-scale Solana (SOL) treasury, recently authorized a new share repurchase program and filed a Resale Prospectus Supplement (https://ibn.fm/h8hV2) with the U.S. Securities and Exchange Commission (“SEC”). The share repurchase program permits the company to buy back up to $1 billion of common stock. These repurchases […]

Rotate your device 90° to view site.